FORMA THERAPEUTICS HOLDINGS (FMTX)
US34633R1041 - Common Stock
| MRQ (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 75.14M | 77.42M | 282.70M | 173.20M | 83.40M | |||
| Marketable Securities | 320.77M | 386.81M | 350.40M | 0.00 | 68.90M | |||
| Receivables | 15.37M | 13.07M | 15.30M | 900.00K | 97.90M | |||
| Other Current Assets | 15.17M | 9.11M | 6.10M | 3.30M | 5.10M | |||
| Total Current Assets | 426.45M | 486.40M | 654.40M | 177.30M | 255.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 35.89M | 36.00M | 1.50M | 5.10M | 7.20M | |||
| Investments And Advances | 0.00 | 26.05M | 12.50M | N/A | N/A | |||
| Other Non-Current Assets | 12.84M | 12.61M | 12.50M | 600.00K | 600.00K | |||
| Total Non-Current Assets | 48.72M | 74.66M | 26.60M | 5.70M | 7.80M | |||
| TOTAL ASSETS | 475.17M | 561.06M | 681.00M | 183.00M | 263.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 28.76M | 29.41M | 26.10M | 19.20M | 20.30M | |||
| Accounts Payable | 3.04M | 4.14M | 4.30M | 3.50M | 6.30M | |||
| Other Current Liabilities | 1.66M | 1.53M | 1.30M | 2.10M | 207.10M | |||
| Total Current Liabilities | 33.46M | 35.09M | 31.70M | 24.90M | 233.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 27.21M | 27.62M | 1.00M | 1.80M | 11.90M | |||
| Total Non-Current Liabilities | 27.21M | 27.62M | 1.00M | 1.80M | 12.00M | |||
| TOTAL LIABILITIES | 60.68M | 62.70M | 32.70M | 26.70M | 245.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -327.11M | -230.37M | -57.40M | 16.70M | -54.60M | |||
| Additional Paid In Capital | 741.55M | 728.68M | 705.60M | 1.10M | 0.00 | |||
| Common Shares | 47.00K | 47.00K | 0.00 | 138.50M | 72.20M | |||
| Shares Outstanding | 47.83M | 47.40M | 47.20M | 36.80M | 36.80M | |||
| Tangible Book Value per Share | 8.67 | 10.51 | 13.73 | 0.49 | -1.48 | |||
| Total Shareholders' Equity | 414.49M | 498.36M | 648.20M | 156.40M | 17.60M | |||
| TOTAL LIABILITIES AND EQUITY | 475.17M | 561.06M | 681.00M | 183.00M | 263.20M | |||
| Statistics | ||||||||
| Current Ratio | 12.74 | 13.86 | 20.64 | 7.12 | 1.09 | |||
| Return On Assets (ROA) | -40.02% | -30.83% | -10.34% | -19.02% | 2.01% | |||
| Return On Equity (ROE) | -45.88% | -34.71% | -10.86% | -22.25% | 30.11% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 25.98% | |||
All data in USD